Synapse - Sergio Giralt

Search Within

Sergio Andres Giralt

Results (1069)

Phase I/II trial of fludarabine in combination with intravenous busulfan and allogeneic progenitor cell support for patients with high risk hematologic malignancies; Dose matters in reduced intensity regimens

Meeting Abstract

Parmar, S.; Rondon, G.; Thall, P. F.; Bassett, R.; de Lima, M.; Hosing, C. M.; Anderlini, P.; Kebriaei, P.; Khouri, I.; Ganesan, P.; more...
Blood (2011)

Fulltext@MSK | Save

Chromosome 7 abnormalities in allogeneic transplantation for AML and MDS

Meeting Abstract

Kota, V.; Saliba, R. M.; Bayraktar, U. D.; Beitinjaneh, A.; Chen, J. J.; Parmar, S.; Giralt, S. A.; Rondon, G.; Ciurea, S. O.; Kebriaei, P.; more...
Blood (2011)

Fulltext@MSK | Save

T-cell depleted allogeneic hematopoietic stem cell transplantation with busulfan, melphalan, and fludarabine conditioning followed by post transplantation donor lymphocyte infusions for patients with relapsed multiple myeloma and high-risk cytogenetics

Meeting Abstract

Koehne, G.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Rosenzweig, M. A.; Heller, G.; Giralt, S.
Blood (2011)

Fulltext@MSK | Save

Immunoglobulin free light chain (FLC) and heavy chain/light chain (HLC) assays - Comparison with electrophoretic responses in multiple myeloma (MM)

Meeting Abstract

Hari, P.; Pasquini, M. C.; Logan, B. R.; Stadtmauer, E. A.; Krishnan, A.; Howard, A.; Alvi, S.; Harding, S.; Carter, S. L.; Rajkumar, V.; more...
Blood (2011)

Fulltext@MSK | Save

Ex-vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission: A comparison of outcomes in two institutions

Meeting Abstract

Bayraktar, U. D.; de Lima, M.; Rima, S. M.; Maloy, M.; Castro-Malaspina, H.; Chen, J. J.; Rondon, G.; Chiattone, A.; Jakubowski, A. A.; Boulad, F.; more...
Blood (2011)

Fulltext@MSK | Save

Double-unit cord blood transplantation (DCBT) for acute leukemia: High disease-free survival in adults and children with comparable survival in European and minority patients

Meeting Abstract

Barker, J. N.; Ponce, D. M.; Gonzales, A. M. R.; Lubin, M. N.; Castro-Malaspina, H.; Giralt, S.; Goldberg, J. D.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
Blood (2011)

Fulltext@MSK | Save

Impact of non high-risk chromosomal abnormalities on the outcome of autologous hematopoietic stem cell transplantation in multiple myeloma

Meeting Abstract

Ahmed, S.; Lin, H.; Baladandayuthapani, V.; Khan, M. A.; Lu, G.; Rondon, G.; Qureshi, S.; Dinh, Y. T.; Bashir, Q.; Shah, N.; more...
Blood (2011)

Fulltext@MSK | Save

Cost analysis of using plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for autologous stem cell mobilization in multiple myeloma patients treated at Memorial Sloan-Kettering Cancer Center (MSKCC)

Meeting Abstract

Adel, N. G.; Duck, E.; Collum, K.; Mccullagh, E.; Reich, L.; Landau, H.; Giralt, S.; Hassoun, H.
Blood (2011)

Fulltext@MSK | Save

Stem cell transplantation for multiple myeloma: Current and future status

Journal Article

Giralt, S.
Hematology-American Society of Hematology Education Program (2011)

Fulltext@MSK | Save

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): A phase 3 biological assignment trial

Journal Article

Krishnan, A.; Pasquini, M. C.; Logan, B.; Stadtmauer, E. A.; Vesole, D. H.; Alyea, E.; Antin, J. H.; Comenzo, R.; Goodman, S.; Hari, P.; more...
Lancet Oncology (2011)

Fulltext@MSK | Save